GSK Chief Praises US, Warns UK's Pharma Decline
Update: 2025-12-12
Description
Dame Emma Walmsley, outgoing head of Britains largest drug developer, GlaxoSmithKline, praises the US as the top investment destination, citing its crucial role in GSKs future growth and its leading market for launching new drugs and vaccines. She acknowledges the UKs strength in life sciences innovation but expresses concerns about the declining appeal for foreign investment in Britain, with other major pharmaceutical companies scaling back plans. The UK government struggles to attract overseas interest due to high energy costs, increased employer National Insurance contributions, and global uncertainty. Dame Emma welcomes the UK-US deal to remove tariffs on UK drug shipments, despite the NHS paying more for medicines.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
